UK markets close in 4 minutes

NuCana plc (NCNA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.1125+0.1425 (+3.59%)
As of 11:06AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close3.9700
Open4.0800
Bid3.9500 x 100
Ask4.3600 x 100
Day's range4.0000 - 4.1793
52-week range3.6900 - 23.7500
Volume17,970
Avg. volume70,553
Market cap8.696M
Beta (5Y monthly)0.94
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    NuCana Announces Completion of ADS Ratio Change

    EDINBURGH, United Kingdom, April 16, 2024 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced that the Company’s previously disclosed plans to change the ratio of its American Depositary Shares (“ADSs”) to its ordinary shares from one (1) ADS, representing one (1) ordinary share, to one (1) ADS representing twenty-five (25) ordinary shares (the "ADS Ratio") has been made effective. The ADS Ratio Change became effective on April 16, 2024 (the “Effective Date”). For the Company's ADS holders,

  • GlobeNewswire

    NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study

    NUC-7738 Reprograms Cancer Cell Lipid Metabolism to Make Tumors Less Aggressive and Promote Cancer Cell Death NUC-7738 Alters Ribosome Biogenesis and the Regulation of Genes Critical for Cancer Growth and Survival SAN DIEGO, April 09, 2024 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced two posters being presented today at the American Association of Cancer Research (AACR) Annual Meeting. Title: Exposing the Heterogeneity of the Lipidome in the TME of Cutaneous Melanoma Following Treatme

  • GlobeNewswire

    NuCana Announces Plan to Implement ADS Ratio Change

    EDINBURGH, United Kingdom, March 27, 2024 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced plans to change the ratio of its American Depository Shares (“ADSs”) to its ordinary shares from one (1) ADS, representing one (1) ordinary share, to one (1) ADS representing twenty-five (25) ordinary shares (the "ADS Ratio"). The change in the ADS Ratio is expected to become effective on or about April 16, 2024 (the "Effective Date"). For the Company's ADS holders, the change in the ADS Ratio has t